US Patent 10494432 Anti-CD79B antibodies and immunoconjugates and methods of use
Patent 10494432 was granted and assigned to Genentech on December, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 22, 2013
Date of Patent
December 3, 2019
Patent Applicant
Patent Application Number
13973669
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10494432 Anti-CD79B antibodies and immunoconjugates and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.